A |
2025-03-24 |
|
Opus Genetics, Inc. |
4 |
A-Award |
--D |
784314.0000 |
784314.0000 |
2 |
0001228627 |
Warrants (right to buy) |
A |
2025-03-24 |
|
Opus Genetics, Inc. |
4 |
A-Award |
--D |
784314.0000 |
861361.0000 |
1 |
0001228627 |
Common Stock |
A |
2024-06-11 |
|
Ocuphire Pharma, Inc. |
4 |
A-Award |
--D |
35181.0000 |
35181.0000 |
2 |
0001228627 |
Stock Option (Right to Buy) |
A |
2024-06-11 |
|
Ocuphire Pharma, Inc. |
4 |
A-Award |
--D |
41143.0000 |
77047.0000 |
1 |
0001228627 |
Common Stock |
D |
2024-05-31 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
9597.0000 |
633680.0000 |
1 |
0001725160 |
Common Stock |
D |
2024-02-12 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
1173.0000 |
643277.0000 |
1 |
0001725160 |
Common Stock |
D |
2024-02-02 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
11552.0000 |
644450.0000 |
2 |
0001725160 |
Common Stock |
A |
2024-02-01 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
A-Award |
--D |
192500.0000 |
192500.0000 |
3 |
0001725160 |
Stock Option (Right to Buy) |
A |
2024-02-01 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
A-Award |
--D |
192500.0000 |
656002.0000 |
1 |
0001725160 |
Common Stock |
A |
2023-06-06 |
|
Ocuphire Pharma, Inc. |
4 |
A-Award |
--D |
9639.0000 |
9639.0000 |
2 |
0001228627 |
Stock Option |
A |
2023-06-06 |
|
Ocuphire Pharma, Inc. |
4 |
A-Award |
--D |
10976.0000 |
35904.0000 |
1 |
0001228627 |
Common Stock |
D |
2023-05-31 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
18526.0000 |
463502.0000 |
2 |
0001725160 |
Common Stock |
D |
2023-05-31 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
9242.0000 |
482028.0000 |
1 |
0001725160 |
Common Stock |
D |
2023-02-14 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
8501.0000 |
491270.0000 |
2 |
0001725160 |
Common Stock |
D |
2023-02-13 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
3332.0000 |
499771.0000 |
1 |
0001725160 |
Common Stock |
D |
2023-02-06 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
572.0000 |
503103.0000 |
2 |
0001725160 |
Common Stock |
D |
2023-02-06 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
9428.0000 |
503675.0000 |
1 |
0001725160 |
Common Stock |
A |
2023-02-01 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
A-Award |
--D |
233908.0000 |
233908.0000 |
2 |
0001725160 |
Stock Option (Right to Buy) |
A |
2023-02-01 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
A-Award |
--D |
161092.0000 |
513103.0000 |
1 |
0001725160 |
Common Stock |
D |
2023-01-17 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
500.0000 |
352011.0000 |
2 |
0001725160 |
Common Stock |
D |
2023-01-17 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
9500.0000 |
352511.0000 |
1 |
0001725160 |
Common Stock |
D |
2023-01-05 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
300.0000 |
362011.0000 |
2 |
0001725160 |
Common Stock |
D |
2023-01-05 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
9700.0000 |
362311.0000 |
1 |
0001725160 |
Common Stock |
D |
2023-01-04 |
|
Ocuphire Pharma, Inc. |
4 |
X-InTheMoney |
--D |
1574.0000 |
0.0000 |
2 |
0001228627 |
Series B Warrant (right to buy) |
A |
2023-01-04 |
|
Ocuphire Pharma, Inc. |
4 |
X-InTheMoney |
--D |
1574.0000 |
24928.0000 |
1 |
0001228627 |
Common Stock |
D |
2022-11-15 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
900.0000 |
372011.0000 |
2 |
0001725160 |
Common Stock |
D |
2022-11-15 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
11600.0000 |
372911.0000 |
1 |
0001725160 |
Common Stock |
D |
2022-11-08 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
12374.0000 |
384511.0000 |
3 |
0001725160 |
Common Stock |
D |
2022-11-07 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
157.0000 |
396885.0000 |
2 |
0001725160 |
Common Stock |
D |
2022-11-07 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
12343.0000 |
397042.0000 |
1 |
0001725160 |
Common Stock |
D |
2022-10-17 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
12500.0000 |
409385.0000 |
1 |
0001725160 |
Common Stock |
D |
2022-10-06 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
10000.0000 |
421885.0000 |
3 |
0001725160 |
Common Stock |
D |
2022-10-05 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
5496.0000 |
431885.0000 |
2 |
0001725160 |
Common Stock |
D |
2022-10-05 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
7004.0000 |
437381.0000 |
1 |
0001725160 |
Common Stock |
D |
2022-09-16 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
1134.0000 |
444385.0000 |
4 |
0001725160 |
Common Stock |
D |
2022-09-16 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
8866.0000 |
445519.0000 |
3 |
0001725160 |
Common Stock |
D |
2022-09-15 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
4074.0000 |
454385.0000 |
2 |
0001725160 |
Common Stock |
D |
2022-09-15 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
8426.0000 |
458459.0000 |
1 |
0001725160 |
Common Stock |
A |
2022-06-13 |
|
Ocuphire Pharma, Inc. |
4 |
A-Award |
--D |
20000.0000 |
20000.0000 |
1 |
0001228627 |
Stock Option (right to buy) |
A |
2022-05-30 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
A-Award |
--D |
333218.0000 |
333218.0000 |
2 |
0001725160 |
Stock Option (Right to Buy) |
A |
2022-05-30 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
A-Award |
--D |
111072.0000 |
466885.0000 |
1 |
0001725160 |
Common Stock |
D |
2022-04-05 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
4369.0000 |
361444.0000 |
1 |
0001725160 |
Common Stock |
D |
2022-04-05 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
3335.0000 |
358109.0000 |
2 |
0001725160 |
Common Stock |
D |
2022-04-05 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
100.0000 |
355813.0000 |
4 |
0001725160 |
Common Stock |
D |
2022-04-05 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
2196.0000 |
355913.0000 |
3 |
0001725160 |
Common Stock |
D |
2022-03-15 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
100.0000 |
365813.0000 |
3 |
0001725160 |
Common Stock |
D |
2022-03-15 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
5322.0000 |
365913.0000 |
2 |
0001725160 |
Common Stock |
D |
2022-03-15 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
4578.0000 |
371235.0000 |
1 |
0001725160 |
Common Stock |
D |
2022-03-07 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
523.0000 |
375813.0000 |
2 |
0001725160 |
Common Stock |
D |
2022-03-07 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
9477.0000 |
376336.0000 |
1 |
0001725160 |
Common Stock |
D |
2022-02-15 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
1370.0000 |
385813.0000 |
3 |
0001725160 |
Common Stock |
D |
2022-02-15 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
5366.0000 |
387183.0000 |
2 |
0001725160 |
Common Stock |
D |
2022-02-15 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
3264.0000 |
392549.0000 |
1 |
0001725160 |
Common Stock |
D |
2022-02-14 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
4850.0000 |
395813.0000 |
5 |
0001725160 |
Common Stock |
D |
2022-02-14 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
259.0000 |
400663.0000 |
4 |
0001725160 |
Common Stock |
D |
2022-02-14 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
2079.0000 |
400922.0000 |
3 |
0001725160 |
Common Stock |
A |
2022-02-10 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
A-Award |
--D |
19245.0000 |
19245.0000 |
6 |
0001725160 |
Stock Option (Right to Buy) |
A |
2022-02-10 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
A-Award |
--D |
7595.0000 |
403001.0000 |
2 |
0001725160 |
Common Stock |
A |
2022-02-10 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
A-Award |
--D |
8203.0000 |
395406.0000 |
1 |
0001725160 |
Common Stock |
D |
2022-02-07 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
1250.0000 |
387203.0000 |
3 |
0001725160 |
Common Stock |
D |
2022-02-07 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
6460.0000 |
388453.0000 |
2 |
0001725160 |
Common Stock |
D |
2022-02-07 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
2290.0000 |
394913.0000 |
1 |
0001725160 |
Common Stock |
D |
2022-01-18 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
3434.0000 |
403769.0000 |
1 |
0001725160 |
Common Stock |
D |
2022-01-18 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
3424.0000 |
400345.0000 |
2 |
0001725160 |
Common Stock |
D |
2022-01-18 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
1300.0000 |
397203.0000 |
4 |
0001725160 |
Common Stock |
D |
2022-01-18 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
1842.0000 |
398503.0000 |
3 |
0001725160 |
Common Stock |
D |
2022-01-05 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
100.0000 |
407203.0000 |
7 |
0001725160 |
Common Stock |
D |
2022-01-05 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
1156.0000 |
407303.0000 |
6 |
0001725160 |
Common Stock |
D |
2022-01-05 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
1106.0000 |
408459.0000 |
5 |
0001725160 |
Common Stock |
D |
2022-01-05 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
3641.0000 |
409565.0000 |
4 |
0001725160 |
Common Stock |
D |
2022-01-05 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
700.0000 |
413206.0000 |
3 |
0001725160 |
Common Stock |
D |
2022-01-05 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
900.0000 |
413906.0000 |
2 |
0001725160 |
Common Stock |
D |
2022-01-05 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
2397.0000 |
414806.0000 |
1 |
0001725160 |
Common Stock |
D |
2021-12-15 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
311.0000 |
419774.0000 |
5 |
0001725160 |
Common Stock |
D |
2021-12-15 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
3001.0000 |
424202.0000 |
1 |
0001725160 |
Common Stock |
D |
2021-12-15 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
1100.0000 |
423102.0000 |
2 |
0001725160 |
Common Stock |
D |
2021-12-15 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
1900.0000 |
421202.0000 |
3 |
0001725160 |
Common Stock |
D |
2021-12-15 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
1117.0000 |
420085.0000 |
4 |
0001725160 |
Common Stock |
D |
2021-12-15 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
1524.0000 |
417730.0000 |
7 |
0001725160 |
Common Stock |
D |
2021-12-15 |
|
Zentalis Pharmaceuticals, Inc. |
4 |
S-Sale |
--D |
520.0000 |
419254.0000 |
6 |
0001725160 |
Common Stock |